| Stage | MCRI | % of rev | MYRG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $146M | 100.00% | $1.3B | 100.00% | MYRG ×8.61 |
| Gross profit | $82M | 56.33% | $171M | 13.60% | MCRI +42.7pp |
| Operating income | $41M | 28.22% | $85M | 6.76% | MCRI +21.5pp |
| Pre-tax income | $42M | 28.79% | $82M | 6.54% | MCRI +22.2pp |
| Net income | $32M | 21.88% | $60M | 4.77% | MCRI +17.1pp |
| Stage | MCRI | MYRG | Gap · A − B |
|---|---|---|---|
| Revenue | $146M100.00% | $1.3B100.00% | MYRG ×8.61 |
| Gross profit | 56.33%$82M | 13.60%$171M | MCRI +42.7pp |
| Operating income | 28.22%$41M | 6.76%$85M | MCRI +21.5pp |
| Pre-tax income | 28.79%$42M | 6.54%$82M | MCRI +22.2pp |
| Net income |
| 21.88%$32M |
| 4.77%$60M |
| MCRI +17.1pp |
No disclosed counterparties: MCRI, MYRG.